Biosimilars: Economic Issues for IP Litigation
In July 2021, the U.S. Food and Drug Administration granted a determination of interchangeability to a biosimilar drug for the first time. This approval has...
Courtroom expertise in complex IP matters.
CRA’s experts provide economic and damages testimony and analysis in support of IP-related litigation in all venues, including US District Court, State Court, ITC, PTAB and in International Arbitration proceedings. Courts increasingly require rigorous economic analysis in the determination of damages awards. Our industry knowledge and expertise in economics, finance, accounting, and business strategy make us uniquely qualified to understand and convey the value and impact of proprietary rights in the marketplace. We prepare and defend well-supported positions based on comprehensive analysis, and deliver clear and compelling testimony.
Engagements
- 01CRA economists assisted TCL in its litigation against EricssonCRA economists assisted TCL in its litigation against Ericsson involving a determination of FRAND rate for cellular standard SEPs in the US and in China. The...View engagement
- 02Allegations of theft of trade secrets and copyright infringementCRA’s expert was retained by defendant to analyze unjust enrichment claims in an intellectual property dispute related to wireless handset technology. CRA’s...View engagement
- 03Valuation of iconic consumer brands for litigation-related impairment testA CRA expert valued certain trademarks to support the SEC’s claim for negligence-based fraud, relating to the failure to timely impair the trademarks. CRA...View engagement